DRW Securities’s Elevance Health ELV Stock Holding History

DRW Securities’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,000	Closed	-$1.17M	–	1376
2025 Q2	$1.17M	Buy	+3,000	New	+$1.21M	0.03%	269

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

DRW Securities's ELV Position: Q1 2026 in Review

DRW Securities sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 732 shares — an estimated $252K sold.

DRW Securities first reported a position in ELV in Q4 2017 and held it in 12 quarters. The position peaked at $1.56M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

DRW Securities reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 732 Elevance Health shares in Q1 2026, an estimated $252K.
DRW Securities first reported a position in Elevance Health in Q4 2017 and held it in 12 quarters.
DRW Securities's Elevance Health position peaked at $1.56M in Q2 2025.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.